✦ LIBER ✦

A randomized prospective comparison of intermittent methotrexate, methotrexate with leucovorin and a methotrexate combination in head and neck cancer

✍ Scribed by R.C. DeConti; D. Schoenfeld

Publisher: Elsevier Science
Year: 1981
Tongue: English
Weight: 207 KB
Volume: 7
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(81)90271-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized prospective comparison of m

A randomized prospective comparison of methotrexate with a combination of methotrexate, bleomycin, and cisplatin in head and neck cancer

✍ Steven E. Vogl; David A. Schoenfeld; Barry H. Kaplan; Harvey J. Lerner; Paul F. 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 1020 KB

Combination chemotherapy with methotrexate, bleomycin, and cis-diamminedichloroplatinum (11) was compared to weekly therapy with methotrexate alone in a randomized prospective trial in 163 patients with recurrent or metastatic squamous cancer of the mucous membranes of the head and neck. The combina

Combined modality treatment of head and

Combined modality treatment of head and neck cancer with cisplatin, bleomycin, methotrexate-leucovorin chemotherapy

✍ Ralph R. Weichselbaum; John R. Clark; Daniel Miller; Marshall R. Posner; Thomas 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 717 KB

Chemotherapy of head and neck cancer: Co

Chemotherapy of head and neck cancer: Combination treatment with cyclophosphamide, adriamycin, methotrexate, and bleomycin

✍ Wittes, Robert E. ;Spiro, Ronald H. ;Shah, Jatin ;Gerold, Frank P. ;Koven, Berna 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 470 KB 👁 1 views

## Abstract A combination of cyclophosphamide, adriamycin, methotrexate, and bleomycin (CAMB) was explored in patients with advanced, nonresectable epidermoid carcinoma from primary sites in the head and neck, recurrent or persistent after radiation or surgery. Objective regression (greater than 50

A phase II study of piritrexim in combin

A phase II study of piritrexim in combination with methotrexate in recurrent and metastatic head and neck cancer

✍ Everett E. Vokes; Isaiah W. Dimery; Charlotte D. Jacobs; Daniel Karp; Arturo Mol 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 468 KB 👁 2 views

Thirty patients with recurrent and/or metastatic head and neck cancer were treated with sequentially administered methotrexate (MTX) and piritrexim (PTX). The treatment schedule consisted of intravenous (IV) MTX (50 mg/m') administered on day 1 and oral PTX (75 mg/mz) administered twice daily on day

Methotrexate content in squamous cell ca

Methotrexate content in squamous cell carcinoma of the head and neck after low-dose methotrexate

✍ Schifeling, David J. ;George, Todd ;McGuirt, Fred ;Capizzi, Robert L. ;Kamen, Ba 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 232 KB

## Abstract Eleven patients with squamous carcinoma of the head and neck who were scheduled for surgical resection or endoscopic biopsy of tumor received 15 mg/m^2^ of methotrexate (MTX). Samples of tumor, normal mucosa, and plasma were obtained at surgery or endoscopy, 18‐24 hours after the last M

Multidrug chemotherapy using bleomycin,

Multidrug chemotherapy using bleomycin, methotrexate, and cisplatin combined with radical radiotherapy in advanced head and neck cancer

✍ Dr. J. Zidan; A. Kuten; Y. Cohen; E. Robinson 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 266 KB 👁 2 views

Thirty-one patients with Stage III-IV head and neck squamous cell cancer were treated by three courses of combination chemotherapy using bleomycin, methotrexate, and cisplatin followed by a radical course of radiation and in two cases by surgery. Of 29 evaluable patients, 4 (14%) achieved complete r